John A. Goss spends much of his time researching Transplantation, Surgery, Liver transplantation, Internal medicine and Immunosuppression. John A. Goss interconnects Andrology, Mortality rate, Complication and Islet in the investigation of issues within Transplantation. The concepts of his Surgery study are interwoven with issues in Liver disease and Urology.
His Liver transplantation research includes themes of Survival rate, Ex vivo, Multivariate analysis and Cirrhosis. His Internal medicine study combines topics in areas such as Gastroenterology and Endocrinology. His Immunosuppression research integrates issues from Organ transplantation, Lymphoproliferative disorders, Disease and Vaccination.
His primary areas of investigation include Liver transplantation, Transplantation, Surgery, Internal medicine and Gastroenterology. His Liver transplantation study which covers Liver disease that intersects with Biliary atresia. His studies deal with areas such as Immunosuppression, Immunology, Retrospective cohort study, Pancreatic islet transplantation and Islet as well as Transplantation.
Immunosuppression is closely attributed to Tacrolimus in his work. Surgery is a component of his Orthotopic liver transplantation, Complication, Survival rate, Single Center and Split liver transplantation studies. In his study, Kupffer cell is strongly linked to Endocrinology, which falls under the umbrella field of Internal medicine.
Liver transplantation, Internal medicine, Transplantation, Surgery and Gastroenterology are his primary areas of study. His Liver transplantation research incorporates elements of Liver disease, Immunosuppression, Cohort and Risk factor. John A. Goss has included themes like Regimen, Neutropenia, Liver tumor, Prednisone and Rituximab in his Immunosuppression study.
John A. Goss has researched Transplantation in several fields, including Mortality rate, Oncology, Hepatocellular carcinoma and Hazard ratio. His Surgery research is multidisciplinary, incorporating elements of Platelet and Cryoprecipitate. His research in Gastroenterology intersects with topics in Ethylmalonic encephalopathy and Large intestine.
His primary areas of study are Internal medicine, Liver transplantation, Retrospective cohort study, Transplantation and Gastroenterology. His work on Hazard ratio, Cirrhosis and Ethylmalonic encephalopathy as part of general Internal medicine research is often related to Metronidazole, thus linking different fields of science. His Liver transplantation study contributes to a more complete understanding of Surgery.
His work deals with themes such as Hepatorenal syndrome, Odds ratio, MEDLINE, Confidence interval and Risk factor, which intersect with Retrospective cohort study. His Organ transplantation study, which is part of a larger body of work in Transplantation, is frequently linked to Patient safety, bridging the gap between disciplines. His Gastroenterology study incorporates themes from Therapeutic approach, ETHE1, Sulfur dioxygenase and Orthotopic Liver Transplant.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Trans-ancestry mutational landscape of hepatocellular carcinoma genomes
Yasushi Totoki;Kenji Tatsuno;Kyle R. Covington;Hiroki Ueda.
Nature Genetics (2014)
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin.
Jay S. Markowitz;Paul Martin;Andrew J. Conrad;James F. Markmann.
Split liver transplantation.
Ronald W. Busuttil;John A. Goss.
Annals of Surgery (1999)
Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.
McDiarmid Sv;Jordan S;Kim Gs;Toyoda M.
Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts
Neal R. Barshes;Samuel Wyllie;John A. Goss.
Journal of Leukocyte Biology (2005)
Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
John A. Goss;Christopher R. Shackleton;Douglas G. Farmer;Walid S. Arnaout.
Annals of Surgery (1997)
Long-term results of pediatric liver transplantation: an analysis of 569 transplants.
John A. Goss;Christopher R. Shackleton;Sue V. McDiarmid;Melinda Maggard.
Annals of Surgery (1998)
Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver transplant recipients.
Timothy C. Lee;Barbara Savoldo;Cliona M. Rooney;Helen E. Heslop.
American Journal of Transplantation (2005)
Microbial Risk Indicators of Early Childhood Caries
P. M. Corby;P. M. Corby;P. M. Corby;J. Lyons-Weiler;W. A. Bretz;T. C. Hart.
Journal of Clinical Microbiology (2005)
Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs).
Barbara Savoldo;John A. Goss;John A. Goss;Markus M. Hammer;Markus M. Hammer;Lan Zhang;Lan Zhang.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: